[ET Net News Agency, 6 July 2026] INNOGEN-B (02591) rose 10.1% to HK$8.9.
It hits an intra-day high of HK$8.94, breaking above the 20-D SMA of HK$8.12, and an intra-day low of HK$7.88. The total shares traded was 1.53 million, with a value of HK$13.16m. The active buy/sell ratio is 65:35, with net buying turnover of HK$3.79m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$171,708, with volume weighted average price of HK$8.698. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$996,768, with volume weighted average price of HK$8.572. The stock has risen a combined 25.5% over the past 3 consecutive trading days.
Basic Information| Nominal | 8.900 | % Chg | +10.15% |
| High | 8.940 | Low | 7.880 |
| Shares Tr | 1.53m | Turnover | 13.16m |
| 10-D SMA | 7.682 | %H.V | 93.401 |
| 20-D SMA | 8.120 | VWAP | 8.607 |
| 50-D SMA | 11.312 | RSI14 | 47.970 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 65:35, with net buying turnover of HK$3.79m, rising a combined 25.5% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 8.90 | +10.15 |
| INNOVENT BIO (01801) | 94.10 | +7.18 |
| KEYMED BIO-B (02162) | 88.00 | +8.17 |
| XTALPI (02228) | 8.50 | +7.59 |
| WUXI XDC (02268) | 65.90 | +6.81 |
| WUXI BIO (02269) | 38.80 | +3.30 |
| BEONE MEDICINES (06160) | 190.20 | +3.88 |
| SKB BIO (06990) | 532.50 | +6.71 |
| AKESO (09926) | 106.30 | +3.81 |
| REMEGEN (09995) | 92.75 | +5.64 |
(ed)
Nominal 
